TFPIb, a Second Product from the Mouse Tissue Factor Pathway Inhibitor (TFPI) Gene

Journal: Thrombosis and Haemostasis
ISSN: 0340-6245
Issue: 1999: 81/1 (Jan) pp.1-164
Pages: 45-49
Ahead of Print: ###MANUSCRIPT_aheadofprint###

TFPIb, a Second Product from the Mouse Tissue Factor Pathway Inhibitor (TFPI) Gene

Jen-Yea Chang, Dougald M. Monroe, Julie A. Oliver, Harold R. Roberts
From the Center for Thrombosis and Hemostasis, University of North Carolina, Chapel Hill, USA


Tissue factor pathway inhibitor (TFPI) contains three Kunitz domains separated by two connecting regions. We have cloned another naturally occurring TFPI gene product from a mouse lung cDNA library which we have called TFPIb. TFPIb is derived from alternative splicing of the TFPI gene. Analysis of the cDNA shows that mouse TFPIb protein is identical to TFPI from the N’-terminus through the second connecting region. However, mouse TFPIb possesses neither a third Kunitz domain nor an Arg, Lys-rich C’-terminus but instead has a completely different C’-terminal (b-domain) sequence which is not homologous to any known protein. Northern blot analyses show that the tissues for mouse TFPIb synthesis are heart and lung; in contrast, TFPI appears in Northern blots of heart and spleen. Both TFPIb and TFPI messages first appear in 7-day-old mouse embryos, but only the TFPI mRNA persists until 17 days. Purified recombinant TFPIb shows an apparent molecular weight of 38 kDa. Kinetic studies indicate that mouse TFPIb is a slow-binding enzyme inhibitor for human factor Xa. In addition, heparin does not enhance the inhibition of factor Xa by mouse TFPIb although it does accelerate factor Xa inhibition by TFPI.

Thrombosis News

Mobile technology identifies people with unknown atrial fibrillation at high risk of stroke – article published in Thrombosis and Haemostasis

The article “Feasibility and cost effectiveness of stroke prevention through community screening...

TH 111.4

The April 2014 TH 111.4 issue of Thrombosis and Haemostasis is a Theme Issue by Guest Editor B....

TH 111.3

Women with atrial fibrillation have a much higher risk for thromboembolic stroke than men suffering...